FIELD: medicine.
SUBSTANCE: pills comprise natural interferon or recombinant -α, -β or -γ manifesting activity in low or high doses. Pills comprising interferon inductor in the amount of 100 mcg to 25 mg or interferon inductor in the amount of l/5-1/20 of therapeutical unit dose with one of recombinant human gene engineering interferons in the amount of 500-1000 IU taken in 2:1 - 3:1 proportion.
EFFECT: enhanced effectiveness in stimulating local oromucosal and systemic immune response; increased antiviral organism resistance.
6 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND MEANS FOR STIMULATING RESISTANCE TO INFECTION | 2001 |
|
RU2191594C1 |
| SUBLINGUAL TABLET MEDICINAL PREPARATION COMPRISING ALPHA- INTERFERON AND METHOD FOR ITS PREPARING | 2003 |
|
RU2234939C1 |
| SUPPOSITORIES AND METHOD OF PROPHYLAXIS AND TREATMENT OF DISEASES TRANSMITTED BY GENITAL TRACTS | 1999 |
|
RU2147873C1 |
| METHOD OF DETERMINING INDIVIDUAL HUMAN BLOOD LEUKOCYTE DRUG SENSITIVITY | 2009 |
|
RU2423705C2 |
| METHOD FOR TREATING THE CASES OF LARYNGEAL PAPILLOMATOSIS | 1999 |
|
RU2147841C1 |
| METHOD OF TREATING POLYPOSIS RHINOSINUSITIS | 1998 |
|
RU2140215C1 |
| METHOD OF INTERFERON-INDUCING OR INTERFERON-ACTIVATED THERAPY AND AN AGENT FOR ITS REALIZATION | 1998 |
|
RU2129011C1 |
| TABLETED INTERFERON PREPARATION FOR ORAL USE | 1999 |
|
RU2175554C2 |
| METHOD OF PREPARING THE ENTERAL PREPARATION CONTAINING ALPHA-INTERFERON AND ENTERAL PREPARATION CONTAINING ALPHA-INTERFERON AS TABLETS | 1993 |
|
RU2083222C1 |
| STABILIZED COMPOSITION POSSESSING ANTIVIRAL, ANTICANCER, IMMUNOMODULATORY, ACTOPROTECTIVE, ANTIMUTAGENIC AND ANTIOXIDANT ACTIVITY | 2018 |
|
RU2690677C1 |
